Simon Spichak on Muck Rack

Simon Spichak

Verified
(He/Him)
Toronto
As seen in: Illumination, Medium, MSN, The Startup, Yahoo Life, MSN UK, Nature, The Guardian, Yahoo Canada, Yahoo News and
Covers:  Neuroscience, health, microbiome, neurotechnology, drug development, blockchain, biology, immunology
Neuroscience MSc 🦔 dad Founded @Resolvve_inc to make therapy affordable for students Words @Being_Patient_ @thedailybeast @TVO @ObserverUK @dailydot

Get in touch with Simon

Contact Simon, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Simon Spichak’s Biography

Read Full Bio →

Hi! I'm an award-winning science communicator and science. I completed my MSc in neuroscience in 2021, focusing on the way that microbes in the gut communicate with the brain. I also represented Ireland on the international stage at Fame Lab - a science communication competition where scientists explain complex topics in a few minutes. I want to leverage my knowledge of science, statistics, and effective communication to explain complex subjects to non-experts.

Simon Spichak’s Journalist Portfolio

See all 10 portfolio items →
We Might Be Treating Schizophrenia All Wrong

We Might Be Treating Schizophrenia All Wrong

For more than 70 years, doctors treated the symptoms of schizophrenia-delusions, hallucinations, cognitive im…

View article →
Will This Drug Help Us Beat Alzheimer’s? Or Will It Doom Its Makers Instead?

Will This Drug Help Us Beat Alzheimer’s? Or Will It Doom Its Makers Instead?

View article →
Crypto Mines Are Making Life a 'Daily Hell' in This Town

Crypto Mines Are Making Life a 'Daily Hell' in This Town

"The natural beauty and tranquility of our area is in jeopardy," C. Roberson's petition on Change.org reads. …

View article →
How Crypto Is Failing Spectacularly to Greenwash Itself

How Crypto Is Failing Spectacularly to Greenwash Itself

"Imagine if keeping your car idling 24/7 produced solved Sudokus you could trade for heroin." That's how one …

View article →
Why Is Everyone So Mad About Aduhelm? - Being Patient

Why Is Everyone So Mad About Aduhelm? - Being Patient

Helped assemble a 2018 consortium that led to a biomarker-based definition of Alzheimer's, controversial beca…

View article →
Startups Are Rushing to Prescribe a New Weight Loss Drug, But Questions Remain

Startups Are Rushing to Prescribe a New Weight Loss Drug, But Questions Remain

For Zoe, it started with a news article. The Food and Drug Administration (FDA) had approved a new weight los…

View article →

Articles

Loneliness Linked to Worse Memory, but Not Faster Cognitive Decline

|
By Simon Spichak 
| Being Patient
Loneliness and social isolation are increasingly recognized as major public health issues, especially in aging adults. A 2023 survey reported that 37 percent of older Americans experienced loneliness, with one in five reporting feeling socially isolated very often. These feelings impact physical and mental health, and in some studies, even increase the risk of dementia.
Open in Who Shared Issue with article?

Research ethics boards need urgent training on Long COVID and myalgic encephalomyelitis

|
By Simon Spichak 
| The Sick Times
Miles Griffis / The Sick Times. Source: Pexels Last year, researchers in Ontario, Canada started recruiting participants for a Long COVID trial testing the feasibility of exercise and rehabilitation. Like many other studies of exercise, it doesn’t use validated measures for post-exertional malaise (PEM).
Open in Who Shared Issue with article?

Genetic Variants Linked To ALS Could Lead to New Treatments

|
By Simon Spichak 
| Being Patient
For decades, amyotrophic lateral sclerosis (ALS) was a disease with no treatment. Within five years, most people with ALS would experience progressive muscle weakness, paralysis and eventually respiratory failure. Then in 2023, the Food and Drug Administration (FDA) approved Qalsody for treating a rare form of ALS linked to a mutation in the SOD1 gene, showing it might be possible to slow the disease.
Open in Who Shared Issue with article?
See all 604 licensed articles (609 Total)

Actions

Share this page

Get in touch with Simon

Contact Simon, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified